Description
Wedica is a medication that contains the active ingredient Trelagliptin Succinate. Here are some key points about it:
Uses: Wedica is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is a highly selective dipeptidyl peptidase-4 inhibitor that is typically used as an add-on treatment when the first-line treatment of metformin is not achieving the expected glycemic goals.
How it works: Trelagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is a highly selective dipeptidyl peptidase-4 inhibitor.
Dosage: 100 mg of Wedica is administered to adults once weekly by mouth.
Side Effects: Among 901 domestic clinical trial cases up to the time of approval, 103 cases (11.4%) showed clinical results that included abnormalities and side effects. These mainly included hypoglycemia, nasopharyngitis, and elevated lipase.
Please note that this information is intended to be used as a guide and does not replace professional medical advice. Always consult with a healthcare professional before starting any new medication.
